INEDSYS
Menu
Theme
Speakers
Prof. ⁨Mohamed El-Kassas⁩

Prof. ⁨Mohamed El-Kassas⁩Verified memberMD

Professor of Endemic Medicine & Hepato-Gastroenterology, Head of Department, Helwan University

Capital UniversityCairoORCID 0000-0002-3396-6894
Speaker · 1 talk
0
Talks given
0
Publications
0
Followers
0
Years

About

Mohamed Mahmoud Zakaria El-Kassas is a Professor and Head of the Endemic Medicine and Hepato-Gastroenterology Department at the Faculty of Medicine, Helwan University, Egypt. He holds an MD in Tropical Medicine from Cairo University and a Postgraduate Diploma in Clinical Research from the University of Liverpool. He is the founder and honorary president of the Egyptian Association for Research and Training in HepatoGastroenterology (EARTH) and the founder and CEO of the Steatotic Liver Disease Study Foundation in the Middle East and North Africa (SLMENA). His clinical and research expertise spans viral hepatitis, MASLD/NASH, hepatocellular carcinoma, and interventional hepatology.

Areas of focus

Hepatology & GastroenterologyViral hepatitis (HCV, HBV)Metabolic-associated steatotic liver disease (MASLD/NASH)Hepatocellular carcinomaInterventional hepatology (radiofrequency ablation, endoscopy)Abdominal ultrasonographyLiver fibrosis assessmentClinical trials in hepatologyEndemic and tropical medicine

Experience & education

Medical Monitor / Study Clinical Scientist · PDC Company

Clinical trial monitoring (Phases II–IV)

2020 — Present

Professor and Head of Department · Helwan University

Endemic Medicine and Hepato-Gastroenterology, Faculty of Medicine

2017 — Present

Co-ordinator, Ethical Review Board · Helwan University

Faculty of Medicine

2017 — Present

Consultant, Hepatogastroenterology · National Hepatology and Tropical Medicine Research Institute

2010 — Present

Consultant, Viral Hepatitis Treatment Center · Damietta Fever Hospital

2009 — Present

Director and Founder, Research Support Center · Helwan University

2019 — 2022

Director, University International Ranking Unit · Helwan University

2017 — 2022

Chancellor of Scientific Research · Helwan University

2018 — 2021

Academic Supervisor, New Cairo Viral Hepatitis Treatment Unit · National Committee for Control of Viral Hepatitis

2014 — 2021

Head of Gastroenterology Endoscopy Unit · Helwan University

University Hospitals, Faculty of Medicine

2016 — 2020

Lecturer, Endemic Medicine and Hepatogastroenterology · Helwan University

Faculty of Medicine

2014 — 2017

Consultant of Hepatology · Port Said Port Authority

2012 — 2017

PG Diploma in Clinical Research · University of Liverpool

United Kingdom

2012 — 2016

Assistant Manager · National Hepatology and Tropical Medicine Research Institute

2011 — 2014

Consultant, Hepatogastroenterology · Damietta Heart and GIT Center

2007 — 2014

MD in Tropical Medicine · Kasr Al-Ainy School of Medicine, Cairo University

2007 — 2011

Assistant Executive Manager · National Committee for Control of Viral Hepatitis, Egypt

2006 — 2011

Specialist / Senior Registrar, Hepato-Biliary and Gastro-Intestinal Diseases · National Hepatology and Tropical Medicine Research Institute

Liver Department

2006 — 2010

Postgraduate Diploma in Hospital Management · Ain Shams University

Faculty of Commerce

2005 — 2006

Master of Tropical Medicine · Ain Shams University

Faculty of Medicine

2004 — 2006

Resident, Hepato-Biliary and Gastro-Intestinal Diseases · National Hepatology and Tropical Medicine Research Institute

Liver Department

2003 — 2006

Publications

Colorectal cancer in metabolic dysfunction-associated steatotic liver disease: an international Delphi consensus statement.

Wu, Chu-Tian, Targher, Giovanni, Byrne, Christopher D, Younossi, Zobair M, Armstrong, Matthew J, Luu, Hung N, et al. · Gut · 2026PubMed

Portal Vein Thrombosis Risk in Cirrhotic Patients With Portal Hypertension on Beta-Blockers: A Multi-Institutional Cohort Study.

Abosheaishaa, Hazem, Elfert, Khaled, Abusuliman, Mohammed, Ismail, Abdellatif, Olimy, Abdullah, Alzamzamy, Ahmed Elsayed, et al. · Liver international : official journal of the International Association for the Study of the Liver · 2026PubMed

Chronic Viral Hepatitis With MASLD: Implications for Clinical and Patient-Reported Outcomes.

Papatheodoridis, George, Buti, Maria, Yilmaz, Yusuf, Yu, Ming-Lung, El-Kassas, Mohamed, Alswat, Khalid, et al. · Journal of gastroenterology and hepatology · 2026PubMed

Characteristics and Outcomes of Patients With Imaging-Defined MASLD and Histological Steatosis Grade S0.

Liu, Wen-Yue, Lian, Li-You, Kim, Seung Up, Cheuk-Fung Yip, Terry, Petta, Salvatore, Nakajima, Atsushi, et al. · The American journal of gastroenterology · 2026PubMed

Impact of Fatigue on Patient-Reported Outcomes and Work Productivity in Chronic Hepatitis B and C: Insights From a Multinational Registry Study.

Yilmaz, Yusuf, Yu, Ming-Lung, Alswat, Khalid, El-Kassas, Mohamed, Ferret, Maria Buti, Papatheodoridis, Georgios, et al. · Journal of viral hepatitis · 2026PubMed

Sexual Dimorphism in Metabolic Dysfunction-Associated Steatotic Liver Disease: The Emerging Role of Non-Coding RNAs.

Chen, Yang En-Xi, Sadek, Amir Amir Samih, Li, Fang, Zhang, Guo-Zheng, Wu, Ning-Lin, Sun, Xiao-Dong, et al. · Comprehensive physiology · 2026PubMed

Physician Perspectives on Hepatitis C Treatment During Pregnancy: A Multinational Multispecialty Survey.

Kushner, Tatyana, Buti, Maria, El-Kassas, Mohamed, Yilmaz, Yusuf, Takahashi, Hirokazu, Eguchi, Yuichiro, et al. · Liver international : official journal of the International Association for the Study of the Liver · 2026PubMed

Changing Cirrhosis Burden in the MENA Region, 1990-2021: From Premature Mortality to Disability (Global Burden of Disease).

Emad, Razan, AlSinani, Siham, El-Kassas, Mohamed, Eslam, Mohamed, Alqahtani, Saleh A, Yilmaz, Yusuf, et al. · Liver international : official journal of the International Association for the Study of the Liver · 2026PubMed

Hepatocellular Carcinoma in Egypt in the Post HCV Elimination Era: Changing Aetiology, Surveillance, and Management Pathways.

El-Kassas, Mohamed, Khalifa, Rofida, Kohla, Mohamed, Marwan, Eman, Abdelmalek, Mohamed O, Shousha, Hend · Liver international : official journal of the International Association for the Study of the Liver · 2026PubMed

Preventive hepatology for MASLD in the MENA region: reframing care from late-stage treatment to early intervention.

El-Kassas, Mohamed, Younossi, Zobair M · Nature reviews. Gastroenterology & hepatology · 2026PubMed

Outcomes and Survival of Egyptian Patients With Hepatitis B-Related Hepatocellular Carcinoma: A Multicentre Retrospective Study.

Barakat, Eman M F, Kohla, Mohamed, Tawheed, Ahmed, Shousha, Hend Ibrahim, Moustafa, Ehab F, Said, Mohamed, et al. · Journal of viral hepatitis · 2026PubMed

Mapping Metabolic Dysfunction-associated Steatotic Liver Disease Models of Care across 17 Middle East and North Africa Countries: Insights into Guidelines, Infrastructure, and Referral Systems.

El-Kassas, Mohamed, AlNaamani, Khalid M, Khalifa, Rofida, Yilmaz, Yusuf, Labidi, Asma, Almattooq, Maen, et al. · Journal of clinical and translational hepatology · 2025PubMed

Hepatitis C Direct-Acting Antivirals in the Immunosuppressed Host: Mechanisms, Interactions, and Clinical Outcomes.

AlKaabi, Hoor, AlSinani, Siham, El-Kassas, Mohamed, Alswat, Khalid A, AlNaamani, Khalid M · Viruses · 2025PubMed

The Seroprevalence, Risk Factors, and Clinical Profile of Hepatitis D in Omani Patients with Chronic Hepatitis B: A Multicenter Cross-Sectional Study.

AlNaamani, Khalid M, Al-Tamtami, Wafa, El-Kassas, Mohamed, Omar, Heba, AlKalbani, Abdullah, Kamath, Bola R, et al. · Journal of clinical medicine · 2025PubMed

Protective Role of Coffee in Chronic Liver Disease: A Focus on Processing.

Khalifa, Rofida, Al-Naamani, Khalid, Elbadry, Mohamed, Zhang, Yuan-Yuan, Alswat, Khalid, El-Kassas, Mohamed · Journal of viral hepatitis · 2025PubMed

On Inedsys

MASLD/MASH: Emerging Therapies and Clinical Practice Updates

Grand Round·Advances in Liver Disease & Transplant Symposium 2026·Oct 2026

Connect

ORCIDLinkedIn